Medivation

Medivation

San Francisco, CA, United States
San Francisco United States
Employees:
630
Market Cap:
$13.52 billion
Revenue:
$943 million
Net Income:
$244.72 million

Medivation is an American biopharmaceutical company focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation, in collaboration with Astellas, is currently developing enzalutamide for multiple stages of prostate cancer and for breast cancer. Wikipedia

Medivation

San Francisco, CA, United States
San Francisco United States

Medivation is an American biopharmaceutical company focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation, in collaboration with Astellas, is currently developing enzalutamide for multiple stages of prostate cancer and for breast cancer. Wikipedia

Employees:
630
Market Cap:
$13.52 billion
Revenue:
$943 million
Net Income:
$244.72 million